Skip to main content
. 2023 Feb 13;83(8):1214–1233. doi: 10.1158/0008-5472.CAN-22-1769

Figure 1.

Figure 1. Myeloma cell–associated therapeutic protein discovery workflow, data sets, and overview. A, Tumor cell–associated therapeutic protein discovery pipeline. B, Stacked bar plot of cell type fractions for each sample, including both tumor BM samples for discovery and normal BM samples for validation. Bar segments are colored by cell types, grouped by data sets. C, Overview of plasma-specific genes and combined plasma and B specific genes, intersections of the two as well as their cellular localization. D, Stacked bar charts showing number of samples with differentially expressed surface proteins in plasma and/or B cells compared with other cell types, colored by data sets.

Myeloma cell–associated therapeutic protein discovery workflow, data sets, and overview. A, Tumor cell–associated therapeutic protein discovery pipeline. B, Stacked bar plot of cell type fractions for each sample, including both tumor BM samples for discovery and normal BM samples for validation. Bar segments are colored by cell types, grouped by data sets. C, Overview of plasma-specific genes and combined plasma and B-specific genes, intersections of the two as well as their cellular localization. D, Stacked bar charts showing number of samples with differentially expressed surface proteins in plasma and/or B cells compared with other cell types, colored by data sets.